Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1989 2
1990 4
1992 2
1995 1
1997 2
1998 1
1999 1
2001 3
2002 4
2003 4
2004 1
2005 1
2006 2
2007 1
2008 1
2012 1
2013 1
2014 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Asymptomatic primary hyperparathyroidism.
Bilezikian JP, Rubin M, Silverberg SJ. Bilezikian JP, et al. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):647-56. doi: 10.1590/s0004-27302006000400010. Arq Bras Endocrinol Metabol. 2006. PMID: 17117290 Review.
Anabolic skeletal therapy for osteoporosis.
Girotra M, Rubin MR, Bilezikian JP. Girotra M, et al. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):745-54. doi: 10.1590/s0004-27302006000400019. Arq Bras Endocrinol Metabol. 2006. PMID: 17117299 Review.
The anabolic effects of parathyroid hormone.
Rubin MR, Cosman F, Lindsay R, Bilezikian JP. Rubin MR, et al. Osteoporos Int. 2002;13(4):267-77. doi: 10.1007/s001980200026. Osteoporos Int. 2002. PMID: 12030541 Review. No abstract available.
Clinical review: Rare causes of hypercalcemia.
Jacobs TP, Bilezikian JP. Jacobs TP, et al. J Clin Endocrinol Metab. 2005 Nov;90(11):6316-22. doi: 10.1210/jc.2005-0675. Epub 2005 Aug 30. J Clin Endocrinol Metab. 2005. PMID: 16131579 Review.
New anabolic therapies in osteoporosis.
Rubin MR, Bilezikian JP. Rubin MR, et al. Endocrinol Metab Clin North Am. 2003 Mar;32(1):285-307. doi: 10.1016/s0889-8529(02)00056-7. Endocrinol Metab Clin North Am. 2003. PMID: 12699304 Review.
New anabolic therapies in osteoporosis.
Rubin MR, Bilezikian JP. Rubin MR, et al. Curr Opin Rheumatol. 2002 Jul;14(4):433-40. doi: 10.1097/00002281-200207000-00018. Curr Opin Rheumatol. 2002. PMID: 12118181 Review.
Differential diagnosis, causes, and management of hypercalcemia.
Chan FK, Koberle LM, Thys-Jacobs S, Bilezikian JP. Chan FK, et al. Curr Probl Surg. 1997 Jun;34(6):445-523. doi: 10.1016/s0011-3840(97)80008-1. Curr Probl Surg. 1997. PMID: 9186232 Free article. Review. No abstract available.
Bone disease in primary hyperparathyroidism.
Parisien M, Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. Parisien M, et al. Endocrinol Metab Clin North Am. 1990 Mar;19(1):19-34. Endocrinol Metab Clin North Am. 1990. PMID: 2192867 Review.
35 results